EUVIMEDEUVIMED entdecken
Open Access

Discovery and Tuning of RNA Editing Guides via High‐Throughput Screening and Chemical Modification

Prince J Salvador iD, Sherry Lin iD, Megan M Chinn iD, Victorio Jauregui-Matos iD, Aashrita Manjunath iD, Isaac Yang iD, Casey S Jacobsen iD, Peter A Beal iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202500735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Prince J Salvador und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Davis, Davis, California, 95616, USA. Hauptthemen laut MEDLINE: RNA Editing, High-Throughput Screening Assays, RNA, Guide, CRISPR-Cas Systems. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine deaminases acting on RNA (ADAR) catalyze the deamination of adenosine to inosine in double‐stranded RNA. Because inosine is read as guanosine during translation, this process enables programmable A‐to‐G recoding at the transcript level. ADARs can be harnessed for therapeutic correction of pathogenic mutations through site‐directed RNA editing with guide RNAs. To expand the design space of editing‐enabling guides, we applied EMERGe, a high‐throughput screening platform, to identify motifs targeting a premature termination codon in the MeCP2 transcript associated with Rett syndrome. This uncovered a guide RNA motif that supported efficient ADAR2‐mediated editing in vitro , featuring a 5′‐GUG‐3' sequence predicted to form an asymmetric loop. To enable therapeutic application, structure–activity relationship studies and chemical optimization were performed, yielding a fully modified guide RNA with 2′‐O‐methyl, 2′‐fluoro, and phosphorothioate linkages. This stabilized guide retained the activity of unmodified RNA and showed enhanced nuclease resistance. The optimized guide induces dose‐dependent editing at two MECP2 loci in reporter assays in HEK293T cells, demonstrating that EMERGe‐selected motifs can be rendered viable in cells through targeted chemical modification. These findings highlight the utility of EMERGe as a discovery platform and establish a pipeline for identifying and optimizing editing‐enabling guide RNA features beyond traditional design rules.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA EditingHigh-Throughput Screening AssaysRNA, Guide, CRISPR-Cas SystemsHumansHEK293 CellsAdenosine DeaminaseMethyl-CpG-Binding Protein 2Structure-Activity RelationshipRNA-Binding Proteins

Stichwörter der Autor:innen

high‐throughput screeningRNAadenosine deaminase acting on RNAnucleic acidoligonucleotides

Substanzen

Adenosine DeaminaseMethyl-CpG-Binding Protein 2MECP2 protein, humanRNA-Binding ProteinsRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Chemistry, University of California, Davis, Davis, California, 95616, USA.

ORCID-Profile: Prince J Salvador, Sherry Lin, Megan M Chinn, Victorio Jauregui-Matos, Aashrita Manjunath, Isaac Yang, Casey S Jacobsen, Peter A Beal

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Salvador, P. J., Lin, S., Chinn, M. M., Jauregui-Matos, V., Manjunath, A., Yang, I., Jacobsen, C. S., & Beal, P. A. (2025). Discovery and Tuning of RNA Editing Guides via High‐Throughput Screening and Chemical Modification. ChemBioChem. https://doi.org/10.1002/cbic.202500735

Vancouver

Salvador PJ, Lin S, Chinn MM, Jauregui-Matos V, Manjunath A, Yang I, et al. Discovery and Tuning of RNA Editing Guides via High‐Throughput Screening and Chemical Modification. ChemBioChem. 2025. doi:10.1002/cbic.202500735

BibTeX
@article{Salvador2025,
  author = {Salvador, Prince J and Lin, Sherry and Chinn, Megan M and Jauregui-Matos, Victorio and Manjunath, Aashrita and Yang, Isaac and Jacobsen, Casey S and Beal, Peter A},
  title = {Discovery and Tuning of RNA Editing Guides via High‐Throughput Screening and Chemical Modification},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202500735}
}
Kostenlos starten →